Who Supplies Ceftriaxone? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ceftriaxone exports, with 850+ registered manufacturers shipping to buyers across 162+ countries — yet a handful of companies dominate the shipments. INNOVA CAPTAB LIMITED holds the largest share at 11.2% (export value: $31.9M). Close behind, UNIVENTIS MEDICARE LIMITED (5.3%, $15.1M). UNILINK PHARMA PRIVATE LIMITED (4.8%, $13.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ceftriaxone? Top Manufacturers & Their Buyers
Flow of Ceftriaxone from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ceftriaxone Supplier Network — Key Market Intelligence
The Ceftriaxone export market from India is led by INNOVA CAPTAB LIMITED, which alone commands a 11.2% share, shipping $31.9M worth of product across 600 shipments. The second-largest exporter, UNIVENTIS MEDICARE LIMITED, contributes $15.1M (5.3%) to the overall market. Combined, the top two suppliers alone account for 16.5% of all Ceftriaxone exports, indicating a relatively concentrated supply base.
Across all 850 tracked manufacturers, the total Ceftriaxone export value stands at $285.4M from 11.3K shipments. The market average shipment value is $25.4K. The single largest buyer relationship in terms of trade value is ROYAL PHARMA 2011 LIMITED, receiving $29.3M worth of product.
The combined buyer network spans 24 named purchasing companies, including ROYAL PHARMA 2011 LIMITED, ELWALIEF INTERNATION, CROWN SOLUTIONS LTD , SAAM GROUP LTD, SHAMS NOORI PHARMA T and 19 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1INNOVA CAPTAB LIMITED
INNOVA CAPTAB LIMITED is the first-largest Ceftriaxone exporter from India, with a market share of 11.2% and a total export value of $31.9M across 600 shipments. Their average shipment value of $53.2K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
INNOVA CAPTAB LIMITED serves 5 named buyers in our database. ROYAL PHARMA 2011 LIMITED is the dominant customer, accounting for 92.0% of this supplier's tracked business. Top customers include:
• ROYAL PHARMA 2011 LIMITED — $29.3M across 552 shipments (92.0% of this supplier's total exports)
• ELWALIEF INTERNATION — $955.6K across 18 shipments (3.0% of this supplier's total exports)
• ROYAL PHARMA 2011 LIMITED — $594.3K across 11 shipments (1.9% of this supplier's total exports)
• TO THE ORDER OF — $548.3K across 10 shipments (1.7% of this supplier's total exports)
• CROWN SOLUTIONS LTD — $465.6K across 9 shipments (1.5% of this supplier's total exports)
Key Insight: INNOVA CAPTAB LIMITED's per-shipment value of $53.2K is 110% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
2UNIVENTIS MEDICARE LIMITED
UNIVENTIS MEDICARE LIMITED is the second-largest Ceftriaxone exporter from India, with a market share of 5.3% and a total export value of $15.1M across 111 shipments. Their average shipment value of $136.0K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
UNIVENTIS MEDICARE LIMITED serves 4 named buyers in our database. SAAM GROUP LTD is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:
• SAAM GROUP LTD — $14.7M across 108 shipments (97.5% of this supplier's total exports)
• SHAMS NOORI PHARMA T — $207.1K across 2 shipments (1.4% of this supplier's total exports)
• SAAM GROUP LIMITED — $128.5K across 1 shipments (0.9% of this supplier's total exports)
• SHAMS NOORI PHARMA T — $41.1K across 0 shipments (0.3% of this supplier's total exports)
Key Insight: UNIVENTIS MEDICARE LIMITED's per-shipment value of $136.0K is 436% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
3UNILINK PHARMA PRIVATE LIMITED
UNILINK PHARMA PRIVATE LIMITED is the third-largest Ceftriaxone exporter from India, with a market share of 4.8% and a total export value of $13.7M across 26 shipments. Their average shipment value of $526.3K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
UNILINK PHARMA PRIVATE LIMITED serves 4 named buyers in our database. PHARMACIE CENTRALE GUINEE is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:
• PHARMACIE CENTRALE GUINEE — $13.5M across 26 shipments (98.8% of this supplier's total exports)
• SOGUIMAP SARL — $116.8K across 0 shipments (0.9% of this supplier's total exports)
• GUIBIOMED — $36.4K across 0 shipments (0.3% of this supplier's total exports)
• AFRIMED SARL — $14.2K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: UNILINK PHARMA PRIVATE LIMITED's per-shipment value of $526.3K is 1975% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
4MEDCELL PHARMA
MEDCELL PHARMA is the fourth-largest Ceftriaxone exporter from India, with a market share of 3.6% and a total export value of $10.3M across 54 shipments. Their average shipment value of $190.4K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
MEDCELL PHARMA serves 5 named buyers in our database. SEA GOLD PHARMA is the dominant customer, accounting for 98.0% of this supplier's tracked business. Top customers include:
• SEA GOLD PHARMA — $10.1M across 53 shipments (98.0% of this supplier's total exports)
• FAQIR ZAMAN LTD — $69.4K across 0 shipments (0.7% of this supplier's total exports)
• MILAD MUSAWAR TRADE — $47.5K across 0 shipments (0.5% of this supplier's total exports)
• EXONIC SHIPPING LLC( — $45.3K across 0 shipments (0.4% of this supplier's total exports)
• V.I.P SHIPPING (L.L. — $45.3K across 0 shipments (0.4% of this supplier's total exports)
Key Insight: MEDCELL PHARMA's per-shipment value of $190.4K is 651% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
5LINCOLN PHARMACEUTICALS LTD
LINCOLN PHARMACEUTICALS LTD is the fifth-largest Ceftriaxone exporter from India, with a market share of 3.0% and a total export value of $8.6M across 54 shipments. Their average shipment value of $159.6K is above the market average of $25.4K, suggesting premium or bulk contract pricing.
LINCOLN PHARMACEUTICALS LTD serves 5 named buyers in our database. KHAN SEHAT LTD is the dominant customer, accounting for 94.3% of this supplier's tracked business. Top customers include:
• KHAN SEHAT LTD — $8.1M across 51 shipments (94.3% of this supplier's total exports)
• UNIQUE PHARMA — $331.8K across 2 shipments (3.9% of this supplier's total exports)
• UNIQUE PHARMA STE UN — $114.5K across 1 shipments (1.3% of this supplier's total exports)
• PLANET PHARMA — $26.9K across 0 shipments (0.3% of this supplier's total exports)
• K S L — $16.1K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: LINCOLN PHARMACEUTICALS LTD's per-shipment value of $159.6K is 529% above the market average of $25.4K, consistent with large-order contracts or value-added formulations.
6AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fifth-largest Ceftriaxone exporter from India, with a market share of 1.1% and a total export value of $3.0M across 184 shipments. Their average shipment value of $16.4K is below the market average of $25.4K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 4 named buyers in our database. EUGIA PHARMA INDUSTRIA FARMACEUTICA is the dominant customer, accounting for 62.2% of this supplier's tracked business. Top customers include:
• EUGIA PHARMA INDUSTRIA FARMACEUTICA — $1.9M across 114 shipments (62.2% of this supplier's total exports)
• AUROVIDA FARMACEUTICA, SA DE CV, — $1.1M across 68 shipments (37.1% of this supplier's total exports)
• GENERICS & SPECIALIT — $19.3K across 1 shipments (0.6% of this supplier's total exports)
• SIMBA PHARMACEUTICAL — $3.3K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (184 shipments) at a per-shipment value of $16.4K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Ceftriaxone Flows
Once Ceftriaxone leaves the manufacturing plants of companies like INNOVA CAPTAB LIMITED and UNIVENTIS MEDICARE LIMITED, it travels to 5 destination markets with a combined import value of $285.4M. Kenya absorbs the largest share at 17.7% ($50.6M), followed by Afghanistan (7.3%) and Mexico (5.9%).
In Kenya — the top destination — named importers include ROYAL PHARMA 2011 LIMITED. In Afghanistan, key buyers are KHAN SEHAT LTD.
This geographic spread reflects Ceftriaxone's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ceftriaxone Go? Top Importing Countries & Their Buyers
Trade flow of Ceftriaxone exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Kenya
Kenya ranks as the first-largest destination for Ceftriaxone imports from India, with a total trade value of $50.6M across 135 shipments — representing a 17.7% share of all Ceftriaxone exports. The average shipment value of $374.5K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftriaxone importers in Kenya: ROYAL PHARMA 2011 LIMITED is the largest buyer, accounting for 59.0% ($29.8M) of this market's total imports.
• ROYAL PHARMA 2011 LIMITED — $29.8M (59.0% of Kenya's total)
Key Insight: Kenya's per-shipment average of $374.5K (1377% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Ceftriaxone imports from India.
2Afghanistan
Afghanistan ranks as the second-largest destination for Ceftriaxone imports from India, with a total trade value of $20.9M across 15 shipments — representing a 7.3% share of all Ceftriaxone exports. The average shipment value of $1.4M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftriaxone importers in Afghanistan: KHAN SEHAT LTD is the largest buyer, accounting for 39.4% ($8.2M) of this market's total imports.
• KHAN SEHAT LTD — $8.2M (39.4% of Afghanistan's total)
Key Insight: Afghanistan's per-shipment average of $1.4M (5387% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Afghanistan is a key market for Ceftriaxone imports from India.
3Mexico
Mexico ranks as the third-largest destination for Ceftriaxone imports from India, with a total trade value of $16.7M across 108 shipments — representing a 5.9% share of all Ceftriaxone exports. The average shipment value of $155.0K is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Ceftriaxone importers in Mexico: AUROVIDA FARMACEUTICA, SA DE CV, is the largest buyer, accounting for 52.0% ($8.7M) of this market's total imports.
• AUROVIDA FARMACEUTICA, SA DE CV, — $8.7M (52.0% of Mexico's total)
• PRODUCTOS FARMACEUTICOS COLLINS, — $2.0M (11.7% of Mexico's total)
Key Insight: Mexico's per-shipment average of $155.0K (511% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Ceftriaxone imports from India.
4Guinea
Guinea ranks as the fourth-largest destination for Ceftriaxone imports from India, with a total trade value of $14.1M across 3 shipments — representing a 5.0% share of all Ceftriaxone exports. The average shipment value of $4.7M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ceftriaxone importers in Guinea: PHARMACIE CENTRALE GUINEE is the largest buyer, accounting for 96.2% ($13.6M) of this market's total imports.
• PHARMACIE CENTRALE GUINEE — $13.6M (96.2% of Guinea's total)
Key Insight: Guinea's per-shipment average of $4.7M (18482% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Guinea is a key market for Ceftriaxone imports from India.
5Ethiopia
Ethiopia ranks as the fifth-largest destination for Ceftriaxone imports from India, with a total trade value of $13.2M across 0 shipments — representing a 4.6% share of all Ceftriaxone exports. The average shipment value of $13.2M is above the global average of $25.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: Ethiopia's per-shipment average of $13.2M (52146% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ethiopia is a key market for Ceftriaxone imports from India.
People Also Ask — Ceftriaxone Supplier & Trade Network
Who are the top suppliers of Ceftriaxone from India?+
Which companies buy Ceftriaxone from Indian manufacturers?+
Where does Ceftriaxone exported from India go?+
What is the market share of the top Ceftriaxone supplier from India?+
What is the average shipment value for Ceftriaxone exports from India?+
Is Ceftriaxone manufactured in India and exported globally?+
Which country imports the most Ceftriaxone from India?+
Who are the buyers of Ceftriaxone in Afghanistan?+
How concentrated is the Ceftriaxone supplier market in India?+
How do I find verified buyers for Ceftriaxone in specific countries?+
Ceftriaxone Trade Network — Key Takeaways
- 1INNOVA CAPTAB LIMITED is India's dominant Ceftriaxone exporter with a 11.2% market share and $31.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 850 suppliers collectively account for 28.9% of all tracked Ceftriaxone exports, with a combined trade value of $285.4M.
- 3Kenya is the largest destination market, absorbing 17.7% of India's Ceftriaxone exports ($50.6M). Afghanistan (7.3%) and Mexico (5.9%) follow.
- 4With 11.3K total shipments averaging $25.4K each, the Ceftriaxone export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include ROYAL PHARMA 2011 LIMITED, ELWALIEF INTERNATION, SAAM GROUP LTD, SHAMS NOORI PHARMA T — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 162 countries
Network value: $285.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ceftriaxone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ceftriaxone.
- 2.Flow Mapping: 850 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 11,257 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 162 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11,257 Verified Shipments
850 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists